Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
Kahn Swick & Foti, LLC issued a lead-plaintiff reminder for a securities class action against Hims & Hers Health (NYSE: HIMS), with a filing deadline of November 2, 2026. The class period runs from August 4, 2025 through July 29, 2026, and alleges the company and certain executives failed to disclose material information in violation of federal securities laws. The triggering event was the FTC's July 29, 2026 lawsuit alleging Hims shared consumers' sensitive health data with third-party ad platforms and deceived users about billing and cancellation practices. HIMS shares fell $4.32, or 14.73%, to close at $25.00 on unusually heavy volume on the FTC news.
Key figures
- Case name
- Velanki v. Hims & Hers Health, Inc. et al.
- Case number
- 26-cv-09313
- Class period
- August 4, 2025 to July 29, 2026
- Stock drop amount
- $4.32
- Stock drop percent
- 14.73%
- Lead plaintiff deadline
- November 2, 2026
- Closing price jul 29 2026
- 25
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.